Vital Therapies Stock Price (NASDAQ:VTL)

Add to My Stocks
$0.31 $0.02 (6.06%) VTL stock closing price Sep 21, 2018 (Closing)
Prev Close* : $0.33
Market Cap:
$13.93M
Day Low: $0.3
52 Week Low: $0.25
Open: $0.33
Volume: -
Day High: $0.34
52 Week High: $9.75
Dividend:
0.00

Latest Stock Market News

Latest Articles

Vital Therapies News - From Partners

Vital Therapies Joins the Russell 3000 Index®   by Globe Newswire on Jun 25, 2018

VTL Stockcharts

View VTL PE ratio, PS ratio stocks charts and compare with peers.
VTL Chart
Note: Compare Vital Therapies stock price history with the index and industry peers.

Vital Therapies Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
-999.0000
PB ratio (
price to book ratio
)
-999.0000

Vital Therapies Returns

ROE
(return on equity)

Vital Therapies Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield
-999.0000

VTL Industry Peers

Company Price Change (%)
Zivo Bioscience (ZIVO)0.170.02 (10.53%)
Atyr Pharma (LIFE)0.780.04 (4.88%)
Fibrocell Science (FCSC)2.160.05 (2.26%)
Akers Biosciences (AKER)0.250 (0%)
Erba Diagnostics (ERBA)0.360 (0%)
Vermillion (VRML)0.710.12 (20.34%)
Quidel Corp (QDEL)64.843.55 (5.19%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Novavax (NVAX)1.60.13 (8.84%)
BioDelivery Sciences (BDSI)2.850.15 (5.56%)
Acadia Pharma (ACAD)20.171.06 (5.55%)
Trevena (TRVN)1.720.08 (4.88%)
ELOXX PHARMACT (ELOX)16.040.74 (4.84%)
Paratek Pharma (PRTK)9.650.4 (4.32%)
Athersys (ATHX)1.940.08 (4.3%)
Top gainers from Medical-Biomed-Genetics industry
* As of Sep 21, 2018
CompanyPriceChange (%)
GTx (GTXI)1.821.49 (92.27%)
Uniquire (QURE)38.462.68 (6.51%)
Retrophin (RTRX)27.821.72 (5.82%)
Enzo Biochem (ENZ)4.090.25 (5.76%)
Dicerna Pharma (DRNA)15.990.81 (4.82%)
Innoviva (INVA)14.950.75 (4.78%)
Agenus (AGEN)20.1 (4.76%)
Top losers from Medical-Biomed-Genetics industry
* As of Sep 21, 2018

Vital Therapies Inc Stock News - Partner Headlines

Vital Therapies Financial Statements

income statement20172016201520142013
Net Sales or Revenues-----
Net Income-52.07M-40.96M-52.02M-47.66M-32.71M
Total Operating Expense52.65M41.26M52.11M50.33M31.39M
View Vital Therapies income statement
balance sheet20172016201520142013
Total Assets60.38M64.02M89.08M108.08M46.58M
Total Liabilities10.34M5.58M6.75M10.51M7.76M
Shareholders Equity50.04M58.44M82.32M97.56M38.81M
View Vital Therapies balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities4.94M-1.37M-3.28M5.82M1.03M
Net Cash from (used by) Operating Activities-40.39M-35.77M-49.95M-40.82M-28.64M
Increase (Decrease) in Prop Plant And Equipment-0.67M-0.55M-2.34M-1.4M-1.48M
View Vital Therapies cash flow statement

Vital Therapies Stock Message Board

Vital Therapies stock lost 6.06%, and the last close price as of Sep 21, 2018 is $0.31 for VTL stock. Vital Therapies market capitalization is $13.93M and it represents the total market value of VTL stock. Vital Therapies valuation can be guaged using various valuation metrics like the price to earnings ratio.

The terms stocks and shares mean the same thing. For Ex: Vital Therapies stock price and Vital Therapies share price mean the same thing. 10,045,225 shares were traded with a closing stock price of $0.31 as of Sep 21, 2018, as can be seen from Vital Therapies stock quote. One can view Vital Therapies stock chart to follow the stock price trend. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. Vital Therapies does not pay dividends. To check the historical stock price movement, all time high, and all time low of VTL, view Vital Therapies stock price history.